Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-06-04Clinical Trial Update: N-acetylcysteine (NAC) for Improving Cognitive Dysfunction in Schizophrenia [Phase 1]
Phase 1 clinical trial evaluating N-acetylcysteine (NAC) for improving cognitive dysfunction in schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2015-06-03Clinical Trial Update: Efficacy, Safety, and Tolerability of TC-5619 as Augmentation Therapy to Improve Negative Symptoms and Cognition in Outpatients With Schizophrenia [Phase 2]
Phase 2 results evaluating the efficacy, safety, and tolerability of TC-5619 as augmentation therapy for negative symptoms and cognitive dys…
-
CLINICAL_TRIALS trial_result · 2015-06-03Clinical Trial Update: Cognitive Behavioral Social Skills Training for Improving Social Functioning in People With Schizophrenia [NA]
Clinical trial update on Cognitive Behavioral Social Skills Training (CBSST) for improving social functioning in people with schizophrenia; …
-
CLINICAL_TRIALS trial_result · 2015-06-02Clinical Trial Update: Safety and Tolerability Study of Aripiprazole IM Depot in Adult Subjects With Schizophrenia [Phase 1]
Phase 1 safety and tolerability study of an intramuscular depot formulation of aripiprazole in adults with schizophrenia. The trial has comp…
-
CLINICAL_TRIALS trial_result · 2015-06-02Clinical Trial Update: Niacin Skin Flush Response in Patients With Schizophrenia [Phase 2, Phase 3]
Completion of a Phase 2/Phase 3 trial evaluating the niacin skin flush response in schizophrenia patients.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-06-02Clinical Trial Update: A Study of RO4917838 in Patients With Sub-optimally Controlled Symptoms of Schizophrenia (NN25307) [Phase 3]
Phase 3 trial of RO4917838 in schizophrenia has completed; the update notes the study status but does not provide results.
-
CLINICAL_TRIALS trial_result · 2015-06-01Clinical Trial Update: Functional Rehabilitation for Older Patients With Schizophrenia [NA]
A US Department of Veterans Affairs trial evaluating functional rehabilitation for older adults with schizophrenia was terminated; results w…
-
CLINICAL_TRIALS trial_result · 2015-05-28Clinical Trial Update: Phosphodiesterase (PDE) Inhibitors Effect on Cognitive Deficits Associated to Schizophrenia [EARLY_Phase 1]
A Phase 1 trial from the University of Copenhagen evaluating phosphodiesterase inhibitors for cognitive deficits in schizophrenia has been t…
-
CLINICAL_TRIALS trial_result · 2015-05-27Clinical Trial Update: Long-Term Safety Extension Trial of Asenapine in Schizophrenia Participants Who Completed Protocol P05688 (P05689) [Phase 3]
This entry notes the completion of a long-term safety extension trial of asenapine in adults with schizophrenia who completed the prior prot…
-
CLINICAL_TRIALS trial_result · 2015-05-27Clinical Trial Update: Factors Association With Poor Physical Function in Older Adults With Schizophrenia
This completed clinical trial investigated factors associated with poor physical function in older adults with schizophrenia or schizoaffect…
-
CLINICAL_TRIALS trial_result · 2015-05-27Clinical Trial Update: Enhancing Synaptic Plasticity and Cognition in Schizophrenia [NA]
This clinical trial update reports on a completed study evaluating approaches to enhance synaptic plasticity in schizophrenia. It addresses …
-
CLINICAL_TRIALS trial_result · 2015-05-21Clinical Trial Update: A Study of Varenicline for Prevention of Relapse to Smoking in Patients With Schizophrenia or Bipolar Disorder [Phase 4]
Phase 4 trial evaluating varenicline to prevent relapse to smoking in patients with schizophrenia or bipolar disorder; study completed with …
-
CLINICAL_TRIALS trial_result · 2015-05-21Clinical Trial Update: Extended Duration Nicotine Replacement Therapy and Bupropion in Smokers With Schizophrenia [Phase 4]
Phase 4 trial evaluating extended duration nicotine replacement therapy with bupropion in smokers with schizophrenia was terminated.
-
CLINICAL_TRIALS trial_result · 2015-05-15Clinical Trial Update: fMRI Cholinergic Mechanisms in Schizophrenia
Completed clinical trial assessing fMRI-based cholinergic mechanisms in schizophrenia; results were posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-05-07Clinical Trial Update: Peony-Glycyrrhiza Decoction (PGD) for Antipsychotic-induced Hyperprolactinemia in Patients With Schizophrenia [Phase 2]
Phase 2 clinical trial of Peony-Glycyrrhiza Decoction (PGD) for antipsychotic-induced hyperprolactinemia in schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2015-04-29Clinical Trial Update: Study Of Talnetant Versus Placebo And Risperidone In Schizophrenia [Phase 2]
Phase 2 clinical trial evaluating talnetant versus placebo and risperidone in schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2015-04-29Clinical Trial Update: A Brief Community Linkage Intervention for Dually Diagnosed Individuals [NA]
Completed clinical trial update on a community linkage intervention for individuals with dual diagnosis, including schizophrenia/psychotic d…
-
CLINICAL_TRIALS trial_result · 2015-04-29Clinical Trial Update: Optimizing Response in Psychosis Study [Phase 4]
Phase 4 clinical trial update for an Optimizing Response in Psychosis study indicates the trial was terminated with results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-04-24Clinical Trial Update: A Comparison of Long-acting Injectable Medications for Schizophrenia [Phase 4]
Phase 4 clinical trial update comparing long-acting injectable antipsychotics for schizophrenia and schizoaffective disorder; results were p…
-
CLINICAL_TRIALS trial_result · 2015-04-17Clinical Trial Update: 6-week Trial of the Efficacy and Safety of Asenapine Compared to Placebo in Participants With an Acute Exacerbation of Schizophrenia (P06124) [Phase 3]
Phase 3 trial comparing asenapine with placebo in adults with acute exacerbation of schizophrenia; the study was completed and results were …
-
CLINICAL_TRIALS trial_result · 2015-04-17Clinical Trial Update: High Dose of Quetiapine in Treating Subjects With Treatment Refractory Schizophrenia or Schizoaffective Disorder [Phase 2, Phase 3]
This clinical trial update concerns high-dose quetiapine for treatment-refractory schizophrenia or schizoaffective disorder, spanning Phase …
-
CLINICAL_TRIALS trial_result · 2015-04-16Clinical Trial Update: Effectiveness of an Interactive Educational Website for Improving the Quality of Mental Health Care for People With Schizophrenia [NA]
This clinical trial update reports on the effectiveness of an interactive educational website aimed at improving quality of mental health ca…
-
CLINICAL_TRIALS trial_result · 2015-04-16Clinical Trial Update: CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness
The VA-sponsored CSP #572 study on genetics of functional disability in schizophrenia and bipolar disorder has completed.
-
CLINICAL_TRIALS trial_result · 2015-04-15Clinical Trial Update: Equivalence of Generic Clozapine to Orally Dissolving Clozapine in Schizophrenia or Schizoaffective Disorder [Phase 4]
This document provides an update on a Phase 4 trial assessing whether a generic clozapine is equivalent to the orally dissolving Clozapine f…
-
CLINICAL_TRIALS trial_result · 2015-04-15Clinical Trial Update: Neurocognitive Training Integrated in OPUS Treatment Versus OPUS Treatment-as-usual [Phase 3]
A Phase 3 clinical trial comparing neurocognitive training integrated into OPUS treatment versus OPUS treatment-as-usual for schizophrenia h…